Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Toxicon ; 222: 106986, 2023 Jan 15.
Article in English | MEDLINE | ID: mdl-36442690

ABSTRACT

Crotoxin (CTX) is a neurotoxin that is isolated from the venom of Crotalus durissus terrificus, which displays immunomodulatory, anti-inflammatory, and anti-tumoral effects. Previous research has demonstrated that CTX promotes the adherence of leukocytes to the endothelial cells in blood microcirculation and the high endothelial venules of lymph nodes, which reduces the number of blood cells and lymphocytes. Studies have also shown that these effects are mediated by lipoxygenase-derived mediators. However, the exact lipoxygenase-derived eicosanoid involved in the CTX effect on lymphocytes is yet to be characterized. As CTX stimulates lipoxin-derived mediators from macrophages and lymphocyte effector functions could be modulated by activating formyl peptide receptors, we aimed to investigate whether these receptors were involved in CTX-induced redistribution and functions of lymphocytes in rats. We used male Wistar rats treated with CTX to demonstrate that Boc2 (butoxycarbonyl-Phe-Leu-Phe-Leu-Phe), an antagonist of formyl peptide receptors, prevented CTX-induced decrease in the number of circulating lymphocytes and increased the expression of the lymphocyte adhesion molecule LFA1. CTX reduced the T and B lymphocyte functions, such as lymphocyte proliferation in response to the mitogen Concanavalin A and antibody production in response to BSA immunization, respectively, which was prevented by the administration of Boc2. Importantly, mesenteric lymph node lymphocytes from CTX-treated rats showed an increased release of 15-epi-LXA4. These results indicate that formyl peptide receptors mediate CTX-induced redistribution of lymphocytes and that 15-epi-LXA4 is a key mediator of the immunosuppressive effects of CTX.


Subject(s)
Crotoxin , Rats , Male , Animals , Crotoxin/pharmacology , Rats, Wistar , Receptors, Formyl Peptide/metabolism , Endothelial Cells , Lymphocytes , Lipoxygenases/metabolism , Lipoxygenases/pharmacology , Crotalus/metabolism
2.
Toxins (Basel) ; 13(11)2021 11 15.
Article in English | MEDLINE | ID: mdl-34822587

ABSTRACT

Snake venom metalloproteinases (SVMP) are involved in local inflammatory reactions observed after snakebites. Based on domain composition, they are classified as PI (pro-domain + proteolytic domain), PII (PI + disintegrin-like domains), or PIII (PII + cysteine-rich domains). Here, we studied the role of different SVMPs domains in inducing the expression of adhesion molecules at the microcirculation of the cremaster muscle of mice. We used Jararhagin (Jar)-a PIII SVMP with intense hemorrhagic activity, and Jar-C-a Jar devoid of the catalytic domain, with no hemorrhagic activity, both isolated from B. jararaca venom and BnP-1-a weakly hemorrhagic P1 SVMP from B. neuwiedi venom. Toxins (0.5 µg) or PBS (100 µL) were injected into the scrotum of mice, and 2, 4, or 24 h later, the protein and gene expression of CD54 and CD31 in the endothelium, and integrins (CD11a and CD11b), expressed in leukocytes were evaluated. Toxins induced significant increases in CD54, CD11a, and CD11b at the initial time and a time-related increase in CD31 expression. In conclusion, our results suggest that, despite differences in hemorrhagic activities and domain composition of the SVMPs used in this study, they behave similarly to the induction of expression of adhesion molecules that promote leukocyte recruitment.


Subject(s)
Bothrops , Crotalid Venoms/toxicity , Metalloendopeptidases/toxicity , Abdominal Muscles/drug effects , Animals , Cell Adhesion Molecules/metabolism , Crotalid Venoms/isolation & purification , Gene Expression Regulation/drug effects , Leukocytes/metabolism , Male , Metalloendopeptidases/isolation & purification , Mice , Microcirculation/drug effects , Platelet Endothelial Cell Adhesion Molecule-1/genetics , Time Factors , Bothrops jararaca Venom
3.
Toxicon ; 51(8): 1357-67, 2008 Jun 15.
Article in English | MEDLINE | ID: mdl-18452962

ABSTRACT

Crotoxin is the main neurotoxic component of Crotalus durissus terrificus snake venom and modulates immune and inflammatory responses, interfering with the activity of leukocytes. In the present work, the effects of crotoxin on the number of blood and lymphatic leukocytes and on lymph nodes and spleen lymphocytes population were investigated. The toxin s.c. administered to male Wistar rats, decreases the number of lymphocytes in blood and lymph circulation and increases the content of B and T-lymphocytes in lymph nodes. These effects were detected 1-2h after treatment. The crotoxin molecule is composed of two subunits, an acidic non-toxic polypeptide, named crotapotin and a toxic basic phospholipase A(2) (PLA(2)). PLA(2), but not crotapotin, decreased the number of circulating blood and lymph lymphocytes. Crotoxin promotes leukocyte adherence to endothelial cells of blood microcirculation and to lymph node high endothelial venules, which might contribute to the drop in the number of circulating lymphocytes. Crotoxin increases expression of the adhesion molecule LFA-1 in lymphocytes. The changes in the expression of the adhesion molecule might contribute, at least in part, for the increased leukocyte adhesion to endothelium. Zileuton, a 5-lipoxygenase inhibitor, blocked the decrease in the number of circulating leukocytes induced by crotoxin and also abolished the changes observed in leukocyte-endothelial interactions, suggesting the involvement of lipoxygenase-derived mediators in the effects of the toxin.


Subject(s)
Cell Adhesion Molecules/physiology , Crotoxin/pharmacology , Lipoxygenase/physiology , Lymphocytes/drug effects , Animals , Cell Adhesion/drug effects , Cell Adhesion Molecules/metabolism , Crotoxin/chemistry , Eicosanoids/metabolism , Eicosanoids/physiology , Endothelial Cells/cytology , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Hydroxyurea/analogs & derivatives , Hydroxyurea/pharmacology , Lipoxygenase Inhibitors/pharmacology , Lymph/cytology , Lymph/metabolism , Lymph Nodes/cytology , Lymph Nodes/metabolism , Lymphatic Vessels/cytology , Lymphatic Vessels/metabolism , Lymphocyte Count , Lymphocytes/blood , Male , Phospholipases A2/pharmacology , Rats , Rats, Wistar , Spleen/cytology , Spleen/metabolism , Thoracic Duct/cytology , Thoracic Duct/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL